【摘要】

摘要：目的：利培酮联合认知行为治疗对精神分裂症残留型症状患者PANSS评分及生活质量的影响。
方法：随机选取我院在2014年1月~2016年1月期间收治的60例精神分裂症残留型症状患者为研究对象，并将其分为观察组和对照组，其中对照组患者采用常规药物利培酮治疗，观察组患者在利培酮治疗的基础上增加认知行为治疗，对比观察两组治疗效果、PANSS评分及生活质量的变化情况。
结果：治疗后，观察组患者PANSS评分及阴性症状评分均明显低于对照组（P<0.05），观察组患者生活质量评分显著高于对照组（P<0.05），且观察组患者SAS及SDS评分与对照组比较具有统计学意义（P<0.05）。
结论：利培酮联合认知行为治疗精神分裂症残留型症状的临床效果显著，能够有效改善阴性症状和焦虑情绪，有助于提升患者的生活质量。

【Abstract】

Objective: To study the effects of risperidone combined cognitive-behavioral therapy on PANSS score and quality of life in patients with residual symptoms of schizophrenia.
Methods: Randomly selected from our hospital from January 2014 to January 2014 in admitted during the period of 60 cases of schizophrenia patients with type residual symptoms as the research object, and it can be divided into observation group and control group, the control group were treated by routine drug risperdal treatment, observation group of patients on the basis of risperidone treatment increase cognitive behavioral therapy, two groups of treatment effect observed, changes of the PANSS score and life quality.
Results: After treatment, the observation group of patients with PANSS score and negative symptom scores were significantly lower than control group (P < 0.05), the observation group of patients quality of life score is significantly higher than control group (P < 0.05), and the observation group of patients with SAS and SDS score compared with the control group with statistical significance (P < 0.05).
Conclusion  : Risperidone combined cognitive behavioral therapy type schizophrenia residual symptoms of clinical effect is remarkable, can effectively improve the negative symptoms and anxiety, help to improve the quality of life of patients.